Ascendis Pharma Total Non-Operating Income/Expense 2015-2024 | ASND
Ascendis Pharma total non-operating income/expense for the twelve months ending December 31, 2024 was $-0.102B, a 407.77% increase year-over-year.
- Ascendis Pharma annual total non-operating income/expense for 2024 was $-0.102B, a 407.77% increase from 2023.
- Ascendis Pharma annual total non-operating income/expense for 2023 was $-0.02B, a 19.41% increase from 2022.
- Ascendis Pharma annual total non-operating income/expense for 2022 was $-0.017B, a 121.01% decline from 2021.